Pathologic Processes clinical trials
The registry lists 119 studies for Pathologic Processes across more than 10 countries. 28 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 52
- Recruiting
- 27
- Active, not recruiting
- 14
- Status unknown
- 14
- Terminated
- 9
- Withdrawn
- 1
Phase
- Phase 2
- 23
- Phase 3
- 15
- Phase 1
- 14
- Phase 4
- 5
Where
- United States
- 58
- Germany
- 16
- Canada
- 14
- United Kingdom
- 11
- Spain
- 11
- Denmark
- 9
Who runs them
University of Colorado, Denver (3) · Bluejay Diagnostics, Inc. (3) · Medtronic Cardiac Ablation Solutions (2) · Ottawa Hospital Research Institute (2) · University Hospital, Bordeaux (2) · Odense University Hospital (2) · Zealand Pharma (2) · University of Pittsburgh (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 119 — search for more.
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruitingNCT071023681 country
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe RegionsRecruitingNCT07654283Phase 26 countries
- Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)RecruitingNCT07585968Not applicable1 country
- Autologous Bone Marrow Aspirate Treatment for Early-Stage OsteonecrosisRecruitingNCT06123481Not applicable1 country
- Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific RegionRecruitingNCT07370207Phase 27 countries
- Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesRecruitingNCT07098806Phase 1/21 country
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruitingNCT06119581Phase 329 countries
- Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)RecruitingNCT06703489Not applicable1 country
- A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)RecruitingNCT07431112Phase 15 countries
- Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyRecruitingNCT07759115Not applicable1 country
- Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)RecruitingNCT054523561 country
- Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBSRecruitingNCT07197944Phase 314 countries
- A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)RecruitingNCT07555483Phase 39 countries
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 21 country
- Auricular VNS Following Intracerebral HemorrhageRecruitingNCT06799390Not applicable1 country
- Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot StudyRecruitingNCT074255871 country
- SPYRAL GEMINI Pilot StudyRecruitingNCT06907147Not applicable6 countries
- Biomarkers in InfectionRecruitingNCT025454781 country
- Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection SpecimensRecruitingNCT06252129Not applicable1 country
- Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT05975983Phase 21 country
- Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICURecruitingNCT07219108Not applicable1 country
- Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Not yet recruitingNCT07162883Phase 3
- Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal SurgeryRecruitingNCT04256798Phase 35 countries
- The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory DysfunctionRecruitingNCT06829706Not applicable1 country
- Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and LactuloseRecruitingNCT04073290Phase 42 countries
- Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsRecruitingNCT06674980Not applicable1 country
- Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic ShockRecruitingNCT05969275Phase 21 country
- Atrial Fibrillation and Diabetes MellitusRecruitingNCT058739201 country
- GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLTerminatedNCT04601584Phase 1/21 country
- Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Active, not recruitingNCT05797246Phase 21 country
- Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel SyndromeCompletedNCT06271538Phase 41 country
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionActive, not recruitingNCT02682511Phase 22 countries
- Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation StudyActive, not recruitingNCT066548951 country
- Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett SyndromeActive, not recruitingNCT07480564Phase 31 country
- MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central NorwayActive, not recruitingNCT039621271 country
- Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected AdultsCompletedNCT007764121 country
- Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)CompletedNCT06162728Phase 1/22 countries
- Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel SyndromeActive, not recruitingNCT07228403Phase 37 countries
- Vorasidenib Expanded Access ProgramApproved for marketingNCT05592743
- A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)Active, not recruitingNCT05606614Phase 32 countries
- The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx StudyCompletedNCT066665041 country
- A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett SyndromeActive, not recruitingNCT05898620Phase 33 countries
- Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)TerminatedNCT05847517Phase 31 country
- Cognition and MRI Markers in MS Patients With Aubagio® TreatmentCompletedNCT03768648Not applicable1 country
- Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple SclerosisCompletedNCT04786821Not applicable1 country
- Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration InterventionCompletedNCT06374225Not applicable1 country
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 39 countries
- SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone MetastasesTerminatedNCT03694015Not applicable1 country
- Defining Causes of Deaths in South and Southeast AsiaCompletedNCT045956565 countries
- COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CFCompletedNCT050545821 country